New Index for Multiple Chronic Conditions Predicts Functional Outcome in Ischemic Stroke

Xiaqing Jiang1, Lu Wang1, Lewis B Morgenstern1

  • 1From the Departments of Epidemiology (X.J., L.B.M., L.D.L.) and Biostatistics (L.W.), School of Public Health, University of Michigan; Stroke Program (L.B.M., E.S.C., L.D.L.), Department of Family Medicine (C.T.C.), Department of Internal Medicine (C.T.C.), and Ann Arbor Healthcare System, Department of Physical Medicine and Rehabilitation (E.S.C.), University of Michigan Medical School; and VA Geriatric Research Education and Clinical Center (C.T.C.), Ann Arbor, MI.

Neurology
|October 7, 2020
PubMed
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
118
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.5K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
221